RESULTS	At the end point , least-squares mean ( + / - SEM ) BNP increased from baseline by 23 + / -5 pg/mL in the placebo group ( n = 1979 ) but decreased by 21 + / -5 pg/mL ( n = 1940 ) in the valsartan group ( P < 0.0001 ) .\